Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The primary goals of this investigation are to provide guidance on how to dose Argatroban in
patients undergoing hemodialysis and to assess the safety and tolerability of Argatroban in
hemodialysis patients. The secondary goal of the study will be to assess the adequacy of
anticoagulation during hemodialysis.